Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 29, 2025 12:39 ET | Source: Allsup

Allsup Employment Services Highlights Employment Support During Spinal Cord Injury Awareness Month

Belleville, Illinois, Sept. 29, 2025 (GLOBE NEWSWIRE) -- September is Spinal Cord Injury Awareness Month and Allsup Employment Services (AES), a Social Security-authorized Employment Network (EN)...
September 15, 2025 08:00 ET | Source: Tiziana Life Sciences Ltd.

Department of Defense Awards Grant to Advance Tiziana Life Sciences Intranasal Anti-CD3 Therapy for Spinal Cord Injury

BOSTON, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
August 18, 2025 12:30 ET | Source: ONWARD Medical NV

ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) The investigational device exemption (IDE) allows initiation of a...
March 19, 2025 09:11 ET | Source: ANEUVO

ANEUVO Launches ASPIRE™ Home Study to Evaluate Home Use of ExaStim®

Los Angeles, CA, March 19, 2025 (GLOBE NEWSWIRE) -- ANEUVO, a leader in non-invasive therapy development, has announced the launch of the ASPIRE™ Home Study, the next phase of clinical research for...
October 26, 2023 07:36 ET | Source: The Insight Partners

Post-acute Care Market Worth $1.37 Billion, Globally, Billion by 2030 - Exclusive Report by The Insight Partners

Pune, India, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Post-acute care encompasses a broad range of services the patient gets after hospitalization. Sometimes, these services are provided as an alternative...
April 05, 2023 08:30 ET | Source: RespireRX Pharmaceuticals Inc.

RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders

Glen Rock, N.J., April 05, 2023 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Markets: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
February 01, 2023 08:30 ET | Source: RespireRX Pharmaceuticals Inc.

ResolutionRx Ltd, a wholly owned subsidiary of RespireRx Pharmaceuticals Inc. Enters into LOI and Term Sheet with Radium Capital for the financing of anticipated Research and Development Credits

Glen Rock, N.J., Feb. 01, 2023 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Markets: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
December 05, 2022 08:30 ET | Source: RespireRX Pharmaceuticals Inc.

RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development

Glen Rock, N.J., Dec. 05, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Markets: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
July 28, 2022 09:15 ET | Source: Innospec Inc.

Innospec Secures Land for Future Expansion at its Primary Personal Care Manufacturing Facility

ENGLEWOOD, Colo., July 28, 2022 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announces the purchase of land which significantly increases the acreage available for future expansion at its...
June 14, 2022 10:00 ET | Source: GRAID Technology

Exxact Corporation Releases New GRAID SupremeRAID™ Powered NVMeoF Storage Solution for AI and HPC Workloads

SANTA CLARA, Calif., June 14, 2022 (GLOBE NEWSWIRE) -- Exxact Corporation, a North America-based leading provider of high-performance computing (HPC), artificial intelligence (AI), and data center...